Your browser doesn't support javascript.
loading
The International Human Papillomavirus Reference Center: Standardization, collaboration, and quality assurance in HPV research and diagnostics.
Arroyo Mühr, Laila Sara; Lagheden, Camilla; Hassan, Sadaf S; Eklund, Carina; Dillner, Joakim.
Affiliation
  • Arroyo Mühr LS; Department of Clinical Science, Intervention and Technology (CLINTEC), Center for Cervical Cancer Elimination, Karolinska Institutet, Stockholm, Sweden.
  • Lagheden C; Department of Clinical Science, Intervention and Technology (CLINTEC), Center for Cervical Cancer Elimination, Karolinska Institutet, Stockholm, Sweden.
  • Hassan SS; Department of Clinical Science, Intervention and Technology (CLINTEC), Center for Cervical Cancer Elimination, Karolinska Institutet, Stockholm, Sweden.
  • Eklund C; Department of Clinical Science, Intervention and Technology (CLINTEC), Center for Cervical Cancer Elimination, Karolinska Institutet, Stockholm, Sweden.
  • Dillner J; Department of Clinical Science, Intervention and Technology (CLINTEC), Center for Cervical Cancer Elimination, Karolinska Institutet, Stockholm, Sweden.
J Med Virol ; 95(12): e29332, 2023 12.
Article in En | MEDLINE | ID: mdl-38115556
ABSTRACT
The International Human Papillomavirus (HPV) Reference Center (IHRC) confirms and assigns type numbers to novel HPV types, maintains a reference clone repository, and issues international proficiency panels for HPV screening and genotyping. Furthermore, the Center coordinates the Global HPV Reference Laboratory Network that promotes collaboration and international exchange of experiences among national HPV reference laboratories, to further international standardization and quality assurance in the HPV field. The established HPV types (n = 225) belong to 5 different genera alpha (n = 65), beta (n = 54), gamma (n = 102), mu (n = 3) and nu (n = 1). Since the last published IHRC overview in 2018, 6 novel types have been established, with 5/6 belonging to the gamma genus and 1/6 to beta genus. Also, 474 reference clones have been provided to 55 different research laboratories and the global proficiency program for HPV genotyping has seen an increasing proficiency (despite a decrease seen in 2019), from 68% proficiency in 2017 to 77.3% in 2022. The first proficiency study for HPV screening found an international proficiency of up to 77%. In summary, increasing complexity of the HPVs and demands on quality assurance in the era of cervical cancer elimination requires international efforts to support proficiency and recognized quality and order among HPV types.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections Limits: Female / Humans Language: En Journal: J Med Virol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Papillomavirus Infections Limits: Female / Humans Language: En Journal: J Med Virol Year: 2023 Document type: Article